Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Revenue

In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth. Eton Pharmaceuticals had revenue of $11.65M in the quarter ending December 31, 2024, with 59.26% growth.

• Revenue (ttm): $39.01M
• Revenue Growth: +23.29%
• P/S Ratio: 11.52
• Revenue / Employee: $1,258,419
• Employees: 31
• Market Cap: 465.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.01M	7.37M	23.29%
Dec 31, 2023	31.64M	10.39M	48.90%
Dec 31, 2022	21.25M	-581.00K	-2.66%
Dec 31, 2021	21.83M	21.79M	55,879.49%
Dec 31, 2020	39.00K	-920.00K	-95.93%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.